Pralidoxime
- Level
- Commodity
- Parent
- 51172300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51172314This classification denotes a cholinergic agonist with the molecular formula C7H9N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7MU9UTP52, chemically known as pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, iodide but generally known as pralidoxime, which bears US NIH Compound Identifier 5353894. European Medicines Agency schedules Pralidoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04002MIG. World Health Organization schedules pralidoxime in its Anatomical Therapeutic Chemical (ATC) Classification. PRALIDOXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, PRALIDOXIME remains the US FDA Preferred Term for this commodity. Pralidoxime bears US NLM identifiers UMLS ID C0071808 and NCI Concept Code C78131. SMILES: O=[NH]/C=C1/N(CCCC1)C.
Same parent
Under 51172300 · 40Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.